Results 1 to 10 of about 56,243 (346)

Antipsychotic agents: efficacy and safety in schizophrenia

open access: yesDrug, Healthcare and Patient Safety, 2012
Arão Nogueira de Araújo,1 Eduardo Pondé de Sena,1,2 Irismar Reis de Oliveira,1,3 Mario F Juruena41Postgraduation Program in Interactive Processes of Organs and Systems, 2Department of Pharmacology, Institute of Health ...
de Araújo AN   +3 more
doaj   +5 more sources

In Elderly Patients With Antipsychotic-Induced Hyperprolactinemia, Could Switching to a Prolactin-Sparing Antipsychotic or Adding a Dopamine Agonist, Rather Than Maintaining the Current Regimen, Normalize the Prolactin Levels Without Triggering Psychotic Relapse or Increasing the Risk of Life-Threatening Adverse Events? A Systematic Review [PDF]

open access: yesBJPsych Open
Aims: Elevated prolactin levels due to antipsychotic drugs are prevalent in elderly patients and may cause multiple complications. Hence, the purpose of the present study is to compare the effectiveness of changing existing antipsychotic treatments with ...
Gaurav Uppal   +4 more
doaj   +2 more sources

Impact of Early Antipsychotic Prescription Choice on Weight Gain in the First 5 Years of Psychotic Illness: a Retrospective Cohort Study [PDF]

open access: yesNeurology and Therapy
Introduction We analysed the effects of antipsychotic drug prescribing in year 1 of treatment for psychosis on future weight gain over 5 years. Methods We studied how weight changed over 5 years after the first diagnosis of psychosis/schizophrenia ...
Adrian Heald   +11 more
doaj   +2 more sources

Onset of Action of Selected Second-Generation Antipsychotics (Pines)–A Systematic Review and Meta-Analyses

open access: yesBiomedicines, 2022
Recommendations for duration of treatment with antipsychotics before considering a switch vary from 2 to 8 weeks, although several studies suggest a rapid onset of action.
Rikke Meyer   +6 more
doaj   +1 more source

Myocarditis in patients on long-term antipsychotics –mechanism, management and recent updates

open access: yesHeliyon, 2023
Objective: Clozapine is the first atypical antipsychotic drug and was frequently cited as the most effective antipsychotic for treatment-resistant schizophrenia, but it is associated with a concert of significant cardiotoxic side effects.
Patterson Daniel   +6 more
doaj   +1 more source

Risperidone-induced Premature Ventricular Complexes in Psychosis: A Case Report [PDF]

open access: yesIndian Journal of Private Psychiatry, 2023
Atypical antipsychotics are known to cause cardiovascular side effects, such as prolonging the QTc interval due to blockade of the potassium repolarization channels, and hence they predispose to ventricular arrhythmias, like premature ventricular ...
Javed A Siddiqui   +2 more
doaj   +1 more source

Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis

open access: yesFrontiers in Psychiatry, 2021
Introduction: Antipsychotic-induced dyslipidemia represents a common adverse effect faced by patients with schizophrenia that increases risk for developing further metabolic complications and cardiovascular disease.
Pruntha Kanagasundaram   +21 more
doaj   +1 more source

Loxapine in patient with clozapine-resistant psychosis [PDF]

open access: yesMental Health Clinician, 2021
Clozapine is recognized as the drug of choice for treatment-refractory schizophrenia, but use may be limited because of strict monitoring requirements and adverse effects including severe neutropenia, seizures, and myocarditis.
Jennifer Erley, PharmD, MBA, BCPS   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy